Annual Total Liabilities
$235.51 M
+$108.77 M+85.82%
December 31, 2023
Summary
- As of February 11, 2025, RVMD annual total liabilities is $235.51 million, with the most recent change of +$108.77 million (+85.82%) on December 31, 2023.
- During the last 3 years, RVMD annual total liabilities has risen by +$142.79 million (+153.99%).
- RVMD annual total liabilities is now at all-time high.
Performance
RVMD Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$196.69 M
+$7.11 M+3.75%
September 30, 2024
Summary
- As of February 11, 2025, RVMD quarterly total liabilities is $196.69 million, with the most recent change of +$7.11 million (+3.75%) on September 30, 2024.
- Over the past year, RVMD quarterly total liabilities has increased by +$13.80 million (+7.55%).
- RVMD quarterly total liabilities is now -16.48% below its all-time high of $235.51 million, reached on December 31, 2023.
Performance
RVMD Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RVMD Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +85.8% | +7.5% |
3 y3 years | +154.0% | +103.3% |
5 y5 years | +218.6% | +112.1% |
RVMD Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +85.8% | -16.5% | +62.5% |
5 y | 5-year | at high | +246.4% | -16.5% | +189.3% |
alltime | all time | at high | +2133.2% | -16.5% | +189.3% |
Revolution Medicines Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $196.69 M(+3.7%) |
Jun 2024 | - | $189.59 M(+3.7%) |
Mar 2024 | - | $182.90 M(-22.3%) |
Dec 2023 | $235.51 M(+85.8%) | $235.51 M(+60.5%) |
Sep 2023 | - | $146.77 M(+2.7%) |
Jun 2023 | - | $142.87 M(+18.0%) |
Mar 2023 | - | $121.03 M(-4.5%) |
Dec 2022 | $126.74 M(-6.4%) | $126.74 M(-12.3%) |
Sep 2022 | - | $144.49 M(+7.9%) |
Jun 2022 | - | $133.96 M(+1.7%) |
Mar 2022 | - | $131.78 M(-2.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $135.42 M(+46.0%) | $135.42 M(+39.9%) |
Sep 2021 | - | $96.77 M(+8.7%) |
Jun 2021 | - | $89.04 M(-0.0%) |
Mar 2021 | - | $89.07 M(-3.9%) |
Dec 2020 | $92.72 M(+36.4%) | $92.72 M(+3.0%) |
Sep 2020 | - | $90.00 M(-3.7%) |
Jun 2020 | - | $93.46 M(+35.4%) |
Mar 2020 | - | $69.03 M(+1.5%) |
Dec 2019 | $67.99 M(-8.0%) | $67.99 M(-1.6%) |
Sep 2019 | - | $69.08 M(-6.6%) |
Dec 2018 | $73.93 M(+601.0%) | $73.93 M |
Dec 2017 | $10.55 M | - |
FAQ
- What is Revolution Medicines annual total liabilities?
- What is the all time high annual total liabilities for Revolution Medicines?
- What is Revolution Medicines annual total liabilities year-on-year change?
- What is Revolution Medicines quarterly total liabilities?
- What is the all time high quarterly total liabilities for Revolution Medicines?
- What is Revolution Medicines quarterly total liabilities year-on-year change?
What is Revolution Medicines annual total liabilities?
The current annual total liabilities of RVMD is $235.51 M
What is the all time high annual total liabilities for Revolution Medicines?
Revolution Medicines all-time high annual total liabilities is $235.51 M
What is Revolution Medicines annual total liabilities year-on-year change?
Over the past year, RVMD annual total liabilities has changed by +$108.77 M (+85.82%)
What is Revolution Medicines quarterly total liabilities?
The current quarterly total liabilities of RVMD is $196.69 M
What is the all time high quarterly total liabilities for Revolution Medicines?
Revolution Medicines all-time high quarterly total liabilities is $235.51 M
What is Revolution Medicines quarterly total liabilities year-on-year change?
Over the past year, RVMD quarterly total liabilities has changed by +$13.80 M (+7.55%)